Publications by authors named "Georg Tschank"

Claim this Profile
1
1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes.
Thomas Böhme, Christian K Engel, Géraldine Farjot, Stefan Güssregen, Torsten Haack, Georg Tschank

Bioorg Med Chem Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.
Cécile Pierre-Eugene, Patrick Pagesy, Tuyet Thu Nguyen, Marion Neuillé, Georg Tschank

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites.
Mark R Sommerfeld, Günter Müller, Georg Tschank, Gerhard Seipke, Paul Habermann

PLoS One· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis